These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1766669)

  • 21. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
    Suzuki T; Hirai H; Yoshida M
    Oncogene; 1994 Nov; 9(11):3099-105. PubMed ID: 7936632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and functional characterization of the chicken c-ros promoter.
    Chen J; Tong J; Tanaka-Sukegawa I; Wang LH
    Cell Growth Differ; 1995 Dec; 6(12):1523-30. PubMed ID: 9019157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional activity of rel family proteins.
    McDonnell PC; Kumar S; Rabson AB; Gélinas C
    Oncogene; 1992 Jan; 7(1):163-70. PubMed ID: 1741161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor.
    Pierce JW; Jamieson CA; Ross JL; Sen R
    J Immunol; 1995 Aug; 155(4):1972-80. PubMed ID: 7636248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
    Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. vRel is an inactive member of the Rel family of transcriptional activating proteins.
    Richardson PM; Gilmore TD
    J Virol; 1991 Jun; 65(6):3122-30. PubMed ID: 1903456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
    La Rosa FA; Pierce JW; Sonenshein GE
    Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel NF-kappa B element within exon 1 of the murine c-myc gene.
    Kessler DJ; Spicer DB; La Rosa FA; Sonenshein GE
    Oncogene; 1992 Dec; 7(12):2447-53. PubMed ID: 1461649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
    Brown AM; Linhoff MW; Stein B; Wright KL; Baldwin AS; Basta PV; Ting JP
    Mol Cell Biol; 1994 May; 14(5):2926-35. PubMed ID: 8164652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the testis c-mos promoter: specific activity in a seminiferous tubule-derived extract and binding of a testis-specific nuclear factor.
    van der Hoorn FA
    Oncogene; 1992 Jun; 7(6):1093-9. PubMed ID: 1375715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter.
    Viswanathan M; Yu M; Mendoza L; Yunis JJ
    Gene; 1996 May; 170(2):271-6. PubMed ID: 8666258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family.
    Le Bail O; Schmidt-Ullrich R; Israël A
    EMBO J; 1993 Dec; 12(13):5043-9. PubMed ID: 8262046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.
    Kralova J; Liss AS; Bargmann W; Pendleton C; Varadarajan J; Ulug E; Bose HR
    J Virol; 2002 Dec; 76(23):11960-70. PubMed ID: 12414938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and analysis of the chicken c-mil promoter: possible involvement of Sp1- and Ets-related proteins.
    Ansieau S; Plaza S; Ferreira E; Dozier C; Stéhelin D
    Genomics; 1993 Dec; 18(3):537-45. PubMed ID: 8307563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50.
    Phi van L
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):39-44. PubMed ID: 8546707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.